4D Molecular Therapeutics
FDMT
#7156
Rank
HK$2.86 B
Marketcap
HK$61.88
Share price
-0.50%
Change (1 day)
-33.57%
Change (1 year)

Revenue for 4D Molecular Therapeutics (FDMT)

Revenue in 2024 (TTM): HK$0.15 Billion

According to 4D Molecular Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$0.15 Billion. In 2023 the company made a revenue of HK$0.16 Billion an increase over the revenue in the year 2022 that were of HK$24.43 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for 4D Molecular Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) HK$0.15 B-2.17%
2023 HK$0.16 B562.2%
2022 HK$24.43 M-82.62%
2021 HK$0.14 B33.29%
2020 HK$0.10 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA